← SynDRA

ABIRATERONE

SynDRA canonical compound SYN0008528 — structure-anchored drug synonym record

All known targets

• CYP17A1
• CYP11B1

Mechanisms of action (all sources)

• Androgen biosynthesis inhibitor
• CYP17A1 MODULATOR

Cross-references

• PubChem CID: 132971
• ChEMBL: CHEMBL254328
• DrugBank: DB05812
• ChEBI: 68642
• KEGG: D09701
• RxNorm: 1100072
• PDB: AER
• TTD: D02STN
• LINCS BRD: BRD-K50071428

Synonyms

• Abiraterona
• CB-7598
• NSC-741232
• Zytiga
• Abiraterone (AR inhibitor)
• androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-(3beta)-
• G819A456D0
• NSC 741232
• abiraterone (usp impurity)
• CB7598
• (3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol
• Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-
• CHEBI:68642
• abirateronum
• RefChem:57133
• L02BX03
• DTXCID501021626
• (3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
• Abiraterone (CB-7598)
• MFCD00924100
• (3beta)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol
• Abiraterone [INN:BAN]
• (3-beta)-17-(3-Pyridinyl)-androsta-5,16-dien-3-ol
• Abirateron;
• UNII-G819A456D0
• Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3b)-
• Abiraterone (Standard)
• ABIRATERONE [MI]
• ABIRATERONE [INN]
• ABIRATERONE [VANDF]
• CB 7630 [as acetate]
• SCHEMBL61108
• ABIRATERONE [WHO-DD]
• MLS006010235
• US9487554, Abiraterone
• GTPL6745
• orb1300971

Reported adverse events

• Cardiac failure
• Fracture
• Hypertension
• Hepatotoxicity
• Cardiac disorder
• Atrial fibrillation
• Angina pectoris
• Arrhythmia
• Bradycardia
• Dyspepsia
• Myalgia
• Tachycardia